Skip to content
OpenCapital
AI Tools
Earnings
Screener
Charts
Watchlist
Pricing
Connect your AI
Get started
Toggle navigation menu
CTO
Citius Oncology, Inc.
CTOR
Operating margin
Operating margin at other companies
Delcath Systems
DCTH
-118.1%
-56.8pp
Iovance Biotherapeutics, Inc.
IOVA
-127.2%
-31.0pp
Immunome
IMNM
-5,947.9%
-12,002pp
Arcus Biosciences
RCUS
-168.6%
-52.7pp
ImmunityBio, Inc.
IBRX
-185.4%
-83.3pp
Nektar Therapeutics
NKTR
-242%
—
Other financials
Income statement
See full
Revenue
$1.7M
—
Gross profit
$1.3M
—
Operating income
-$28.6M
-283%
Net income
-$26.6M
-244%
EPS (diluted)
-$0.27
-145%
Balance sheet
See full
Cash & equivalents
$2.6M
+2,350,466%
Total equity
$35.3M
-1.0%
Total assets
$100.7M
+10.1%
Cash flow
See full
Operating cash flow
-$3.8M
-179%
Valuation
See full
Market cap
$60.45M
-74.7%
Returns & leverage
See full
Return on equity
-119.9%
+46.7pp
Current ratio
0.5×
+0.1×